Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages

  Poole, Elizabeth M ^a,b,c   Curtin, Karen ^d   Hsu, Li ^a   Duggan, David J ^f   Makar, Karen W ^a   Xiao, Liren ^a   Carlson, Christopher S ^a   Caan, Bette J ^g   Potter, John D ^a,e   Slattery, Martha L ^d   Ulrich, Cornelia M ^a,e,h  

^a Fred Hutchinson Cancer Research Center   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Colorectal cancer; Colorectal polyps; Genetics; IL23R

Indexed keywords

INTERLEUKIN 23 RECEPTOR; K RAS PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR MARKER;

ADULT; ARTICLE; CALORIC INTAKE; CANCER GENETICS; CANCER RISK; CASE CONTROL STUDY; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; DNA EXTRACTION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RISK FACTORS;

EID: 84858793804     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.11.001     Document Type: Article

References (38)

1. Ahern P.P., Izcue A., Maloy K.J., Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol Rev 2008, 226:147-159.
2. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201(2):233-240.
3. Langowski J.L., Zhang X., Wu L., Mattson J.D., Chen T., Smith K., et al. IL-23 promotes tumour incidence and growth. Nature 2006, 442(7101):461-465.
4. Teng M.W., Andrews D.M., McLaughlin N., von Scheidt B., Ngiow S.F., Moller A., et al. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci U S A 2010, 107(18):8328-8333.
5. Abraham C., Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2009, 60:97-110.
6. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198(12):1951-1957.
7. Chan J.R., Blumenschein W., Murphy E., Diveu C., Wiekowski M., Abbondanzo S., et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 2006, 203(12):2577-2587.
8. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40(6):710-712.
9. Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3(4):e58.
10. Glas J., Seiderer J., Wetzke M., Konrad A., Torok H.P., Schmechel S., et al. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2007, 2(9):e819.
11. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
12. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463.
13. Triantafillidis J.K., Nasioulas G., Kosmidis P.A. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009, 29(7):2727-2737.
14. Potter J.D., Bostick R.M., Grandits G.A., Fosdick L., Elmer P., Wood J., et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit case-control Study. Cancer Epidemiol Biomarkers Prev 1996, 5(10):779-784.
15. Slattery M.L., Potter J., Caan B., Edwards S., Coates A., Ma K.N., et al. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997, 57(1):75-80.
16. Slattery M.L., Edwards S., Curtin K., Ma K., Edwards R., Holubkov R., et al. Physical activity and colorectal cancer. Am J Epidemiol 2003, 158(3):214-224.
17. Spirio L.N., Samowitz W., Robertson J., Robertson M., Burt R.W., Leppert M., et al. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 1998, 20(4):385-388.
18. Samowitz W.S., Albertsen H., Herrick J., Levin T.R., Sweeney C., Murtaugh M.A., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005, 129(3):837-845.
19. Samowitz W.S., Curtin K., Ma K.N., Edwards S., Schaffer D., Leppert M.F., et al. Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer 2002, 99(4):597-602.
20. Samowitz W.S., Curtin K., Schaffer D., Robertson M., Leppert M., Slattery M.L. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 2000, 9(11):1193-1197.
21. Slattery M.L., Curtin K., Anderson K., Ma K.N., Ballard L., Edwards S., et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000, 92(22):1831-1836.
22. Samowitz W.S., Albertsen H., Sweeney C., Herrick J., Caan B.J., Anderson K.E., et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006, 98(23):1731-1738.
23. Issa J.P., Shen L., Toyota M. CIMP, at last. Gastroenterology 2005, 129(3):1121-1124.
24. Samowitz W.S. The CpG island methylator phenotype in colorectal cancer. J Mol Diagn 2007, 9(3):281-283.
25. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74(1):106-120.
26. Conneely K.N., Boehnke M. So many correlated tests, so little time! Rapid adjustment of p values for multiple correlated tests. Am J Hum Genet 2007, 81(6).
27. Gauderman W.J., Murcray C., Gilliland F., Conti D.V. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007, 31(5):383-395.
28. Slattery M.L., Curtin K., Wolff R.K., Boucher K.M., Sweeney C., Edwards S., et al. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 2009, 52(7):1304-1311.
29. Burton P., Gurrin L., Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998, 17(11):1261-1291.
30. Kuss O., McLerran D. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007, 87(3):262-269.
31. Campbell P.T., Jacobs E.T., Ulrich C.M., Figueiredo J.C., Poynter J.N., McLaughlin J.R., et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010, 102(6):391-400.
32. Limsui D., Vierkant R.A., Tillmans L.S., Wang A.H., Weisenberger D.J., Laird P.W., et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 2010, 102(14):1012-1022.
33. Slattery M.L., Anderson K., Curtin K., Ma K.N., Schaffer D., Samowitz W. Dietary intake and microsatellite instability in colon tumors. Int J Cancer 2001, 93(4):601-607.
34. Loftus E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006, 35(3):517-531.
35. Xie J., Itzkowitz S.H. Cancer in inflammatory bowel disease. World J Gastroenterol 2008, 14(3):378-389.
36. Momozawa Y., Mni M., Nakamura K., Coppieters W., Almer S., Amininejad L., et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 2011, 43(1):43-47.
37. Chen J., Lu Y., Zhang H., Ding Y., Ren C., Hua Z., et al. A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog 2010, 49(10):862-868.
38. Gaj P., Mikula M., Wyrwicz L.S., Regula J., Ostrowski J. Barrett's esophagus associates with a variant of IL23R gene. Acta Biochim Pol 2008, 55(2):365-369.